Newfound hormone holds hope for diabetes treatment

Harvard Stem Cell Institute Co-Director Doug Melton, right, and Peng Yi, a post doctoral fellow in his lab, review data April 5 in Melton's lab in Cambridge, Mass.

http://www.livingstondaily.com/usatoday/article/2112673